Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexanian

Showing results (201-210 of 371) with videos related to

Pageof 38
Sort By:
Restorative Neurology and Neuroscience|January 7, 2011
Survival of neurally induced mesenchymal cells may determine degree of motor recovery in injured spinal cord ratsArshak R Alexanian, Wai-Meng Kwok, Danijel Pravdic, et al.
Health Security|January 12, 2022
iGEM and Gene Drives: A Case Study for GovernancePiers Millett, Tessa Alexanian, Megan J Palmer, et al.
Applied Biosafety : Journal of the American Biological Safety Association|August 12, 2024
Developing a Common Global Baseline for Nucleic Acid Synthesis ScreeningNicole E Wheeler, Sarah R Carter, Tessa Alexanian, et al.
Bone Marrow Transplantation|July 5, 2001
Impact of complete remission with intensive therapy in patients with responsive multiple myelomaR Alexanian, D Weber, S Giralt, et al.
Seminars in Oncology|April 30, 2003
2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemiaDonna M Weber, Meletios A Dimopoulos, Kay Delasalle, et al.
American Journal of Hematology|September 1, 1988
Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemiaJ R Quesada, R Alexanian, R Kurzrock, et al.
Cellular Reprogramming|July 2, 2011
Feline bone marrow-derived mesenchymal stem cells express several pluripotent and neural markers and easily turn into neural-like cells by manipulation with chromatin modifying agents and neural inducing factorsZhiying Zhang, Dennis J Maiman, Shekar N Kurpad, et al.
American Journal of Clinical Oncology|June 23, 2011
Bortezomib-cyclophosphamide-dexamethasone for relapsing multiple myelomaWeijun Fu, Kay Delasalle, Jialei Wang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 20, 2016
HYPOGLYCEMIA RATES AFTER RESTRICTION OF HIGH-DOSE GLARGINE IN HOSPITALIZED PATIENTSSun Y Lee, Gulce Askin, Marie E McDonnell, et al.
Anticancer Research|October 23, 2009
Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growthAnna Alexanian, Victoriya A Rufanova, Bradley Miller, et al.
Pageof 38

Showing results (201-210 of 371) with videos related to

Sort By:
Pageof 38
Restorative Neurology and Neuroscience|January 7, 2011
Survival of neurally induced mesenchymal cells may determine degree of motor recovery in injured spinal cord ratsArshak R Alexanian, Wai-Meng Kwok, Danijel Pravdic, et al.
Health Security|January 12, 2022
iGEM and Gene Drives: A Case Study for GovernancePiers Millett, Tessa Alexanian, Megan J Palmer, et al.
Applied Biosafety : Journal of the American Biological Safety Association|August 12, 2024
Developing a Common Global Baseline for Nucleic Acid Synthesis ScreeningNicole E Wheeler, Sarah R Carter, Tessa Alexanian, et al.
Bone Marrow Transplantation|July 5, 2001
Impact of complete remission with intensive therapy in patients with responsive multiple myelomaR Alexanian, D Weber, S Giralt, et al.
Seminars in Oncology|April 30, 2003
2-Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemiaDonna M Weber, Meletios A Dimopoulos, Kay Delasalle, et al.
American Journal of Hematology|September 1, 1988
Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemiaJ R Quesada, R Alexanian, R Kurzrock, et al.
Cellular Reprogramming|July 2, 2011
Feline bone marrow-derived mesenchymal stem cells express several pluripotent and neural markers and easily turn into neural-like cells by manipulation with chromatin modifying agents and neural inducing factorsZhiying Zhang, Dennis J Maiman, Shekar N Kurpad, et al.
American Journal of Clinical Oncology|June 23, 2011
Bortezomib-cyclophosphamide-dexamethasone for relapsing multiple myelomaWeijun Fu, Kay Delasalle, Jialei Wang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 20, 2016
HYPOGLYCEMIA RATES AFTER RESTRICTION OF HIGH-DOSE GLARGINE IN HOSPITALIZED PATIENTSSun Y Lee, Gulce Askin, Marie E McDonnell, et al.
Anticancer Research|October 23, 2009
Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growthAnna Alexanian, Victoriya A Rufanova, Bradley Miller, et al.
Pageof 38